ArticleFrontiers in medicine2026
The role of a multidisciplinary approach in the early and differential diagnosis of inflammatory bowel disease-related spondyloarthritis: insights from a cross-sectional study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Inflammatory bowel disease-related spondyloarthritis (IBD-SpA) commonly complicates IBD. Early diagnosis is essential; however, it is often delayed due to clinical heterogeneity and the lack of specific diagnostic criteria. This study aimed to evaluate the outcomes of close collaboration between gastroenterologists and rheumatologists in the classification of the musculoskeletal (MSK) manifestations in IBD patients, focusing on the early diagnosis of IBD-SpA and its differentiation from other conditions. Methods: Consecutive IBD outpatients underwent a comprehensive rheumatologic evaluation during a joint rheumatologist-gastroenterologist consultation, including the DETection of Arthritis in Inflammatory boweL diseases (DETAIL) screening questionnaire, and, when appropriate, laboratory and imaging investigations. Suspected IBD-SpA cases were classified as newly diagnosed IBD-SpA, having an alternative arthropathy diagnosis, or having non-specific arthralgias, and their characteristics were analyzed. Results: A total of 605 IBD patients were evaluated. At the first assessment, 81 patients had a pre-existing diagnosis of SpA and 117 patients of suspected IBD-SpA cases were identified. Among the latter assessment, 18 (15%) were confirmed as new IBD-SpA diagnoses, resulting in a 22% relative increase in the total number of SpA cases and raising the overall prevalence from 13.4 to 16.4%. Patients with axial involvement experienced a longer diagnostic delay (mean 12.4 vs. 2.9 years, Conclusion: The multidisciplinary approach enables early and accurate diagnosis of IBD-SpA, minimizing the risk of misclassification of musculoskeletal manifestations and unwarranted treatment changes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.